Royce Micro-Cap Trust, Inc. (RMT) Reaches $9.61 Formed H&S; Cogentix Medical, Inc. (CGNT) Had 2 Bullish Analysts

Cogentix Medical, Inc. (NASDAQ:CGNT) Logo

Royce Micro-Cap Trust, Inc. (RMT) formed H&S with $8.84 target or 8.00% below today’s $9.61 share price. Royce Micro-Cap Trust, Inc. (RMT) has $369.11 million valuation. The stock decreased 0.41% or $0.04 during the last trading session, reaching $9.61. About 128,945 shares traded or 10.42% up from the average. Royce Micro-Cap Trust, Inc. (NYSE:RMT) has risen 13.38% since April 25, 2017 and is uptrending. It has outperformed by 1.83% the S&P500.

Among 4 analysts covering Cogentix Medical (NASDAQ:CGNT), 2 have Buy rating, 0 Sell and 2 Hold. Therefore 50% are positive. Cogentix Medical had 10 analyst reports since November 5, 2015 according to SRatingsIntel. The company was maintained on Wednesday, November 8 by Roth Capital. Aegis Capital downgraded the shares of CGNT in report on Tuesday, March 13 to “Hold” rating. The firm earned “Buy” rating on Friday, October 6 by JMP Securities. The stock has “Neutral” rating by Roth Capital on Friday, May 6. Roth Capital upgraded Cogentix Medical, Inc. (NASDAQ:CGNT) rating on Thursday, November 5. Roth Capital has “Buy” rating and $3 target. The stock of Cogentix Medical, Inc. (NASDAQ:CGNT) earned “Buy” rating by Roth Capital on Tuesday, July 18. On Wednesday, August 2 the stock rating was maintained by Roth Capital with “Buy”. TH Capital upgraded the stock to “Buy” rating in Thursday, November 5 report. The firm has “Hold” rating given on Friday, March 23 by Roth Capital. See Cogentix Medical, Inc. (NASDAQ:CGNT) latest ratings:

23/03/2018 Broker: Roth Capital Rating: Hold New Target: $3.8500 Downgrade
13/03/2018 Broker: Aegis Capital Old Rating: Buy New Rating: Hold Old Target: $4.75 Downgrade
01/12/2017 Broker: Aegis Capital Rating: Buy New Target: $4.75 Initiates Coverage On
08/11/2017 Broker: Roth Capital Old Rating: Buy New Rating: Buy New Target: $4 Maintain

Investors sentiment decreased to 1.42 in 2017 Q4. Its down 0.19, from 1.61 in 2017Q3. It is negative, as 5 investors sold Royce Micro-Cap Trust, Inc. shares while 19 reduced holdings. 11 funds opened positions while 23 raised stakes. 9.45 million shares or 6.35% less from 10.09 million shares in 2017Q3 were reported. Brown Advisory Incorporated holds 82,802 shares or 0% of its portfolio. Cambridge Inv Rech Advsrs holds 0% in Royce Micro-Cap Trust, Inc. (NYSE:RMT) or 16,606 shares. Vigilant Cap Mngmt Limited Liability Company has 0% invested in Royce Micro-Cap Trust, Inc. (NYSE:RMT) for 509 shares. Da Davidson And invested 0.01% in Royce Micro-Cap Trust, Inc. (NYSE:RMT). Rivernorth Mgmt Limited Liability Co has 0.42% invested in Royce Micro-Cap Trust, Inc. (NYSE:RMT) for 647,033 shares. Creative Planning holds 0% or 50,048 shares in its portfolio. Royal National Bank & Trust Of Canada reported 162,561 shares. Raymond James Financial Services has 0% invested in Royce Micro-Cap Trust, Inc. (NYSE:RMT) for 32,088 shares. North Star Asset Management Inc invested in 70,773 shares or 0.06% of the stock. Moreover, Cornerstone has 0.59% invested in Royce Micro-Cap Trust, Inc. (NYSE:RMT) for 544,645 shares. Lpl Financial accumulated 106,204 shares. Laurion Cap Mngmt Lp reported 52,888 shares or 0% of all its holdings. Illinois-based North Star Invest Management has invested 0% in Royce Micro-Cap Trust, Inc. (NYSE:RMT). 1607 Cap Prtnrs Limited Liability accumulated 146,401 shares. Blue Bell Private Wealth Lc stated it has 0.4% in Royce Micro-Cap Trust, Inc. (NYSE:RMT).

It closed at $3.85 lastly. It is down 110.93% since April 25, 2017 and is uptrending. It has outperformed by 99.38% the S&P500.

Cogentix Medical, Inc., a medical device company, designs, develops, makes, and markets fiberoptic and video endoscopy products under the PrimeSight brand worldwide. The company has market cap of $234.56 million. The firm offers endoscopes, such as cystoscopes, laryngoscopes, transnasal esophagoscopes, and bronchoscopes for medical use; and borescopes for industrial use, as well as digital processing units for medical use. It currently has negative earnings. It also provides EndoSheath Protective Barrier, a sterile, single-use microbial barrier for use with flexible endoscopes.

Cogentix Medical, Inc. (NASDAQ:CGNT) Ratings Chart